These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 36531463)

  • 1. Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology.
    Memaj P; Jornayvaz FR
    Front Endocrinol (Lausanne); 2022; 13():1031633. PubMed ID: 36531463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes.
    Cusi K; Sanyal AJ; Zhang S; Hartman ML; Bue-Valleskey JM; Hoogwerf BJ; Haupt A
    Diabetes Obes Metab; 2017 Nov; 19(11):1630-1634. PubMed ID: 28417532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease: identical etiologic factors in patients with type 1 and type 2 diabetes.
    de Vries M; El-Morabit F; van Erpecum KJ; Westerink J; Bac ST; Kaasjager HAHK; de Valk HW
    Eur J Intern Med; 2022 Jun; 100():77-82. PubMed ID: 35387749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic determinants of NAFLD in adults with type 1 diabetes.
    Serdarova M; Dimova R; Chakarova N; Grozeva G; Todorova A; Tsarkova P; Marinova C; Popov D; Mateva L; Tankova T
    Diabetes Res Clin Pract; 2022 Apr; 186():109819. PubMed ID: 35248654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic Hepatopathy.
    Mertens J; De Block C; Spinhoven M; Driessen A; Francque SM; Kwanten WJ
    Front Pharmacol; 2021; 12():768576. PubMed ID: 34759828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.
    Muzurović E; Mikhailidis DP; Mantzoros C
    Metabolism; 2021 Jun; 119():154770. PubMed ID: 33864798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with surrogate markers of insulin resistance in patients with type 1 diabetes.
    de Vries M; Westerink J; El-Morabit F; Kaasjager HAHK; de Valk HW
    Diabetes Res Clin Pract; 2022 Apr; 186():109827. PubMed ID: 35283265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for non-alcoholic fatty liver disease in children and adolescents with type 1 diabetes mellitus: a cross-sectional analysis.
    Kummer S; Klee D; Kircheis G; Friedt M; Schaper J; Häussinger D; Mayatepek E; Meissner T
    Eur J Pediatr; 2017 Apr; 176(4):529-536. PubMed ID: 28213828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 1 Diabetes and Non-Alcoholic Fatty Liver Disease: When Should We Be Concerned? A Nationwide Study in Brazil.
    Barros BSV; Santos DC; Pizarro MH; del Melo LGN; Gomes MB
    Nutrients; 2017 Aug; 9(8):. PubMed ID: 28809804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical characteristics of non-alcoholic fatty liver disease in newly diagnosed patients with ketosis-onset diabetes.
    Li TT; Wang AP; Lu JX; Chen MY; Zhao CC; Tang ZH; Li LX; Jia WP
    Diabetes Metab; 2018 Nov; 44(5):437-443. PubMed ID: 29631765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
    Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
    BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic Fatty Liver Disease and Diabetes: An Epidemiological Perspective.
    Rhee EJ
    Endocrinol Metab (Seoul); 2019 Sep; 34(3):226-233. PubMed ID: 31565874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?
    Valenti L; Bugianesi E; Pajvani U; Targher G
    Liver Int; 2016 Nov; 36(11):1563-1579. PubMed ID: 27276701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prevalence of Nonalcoholic Fatty Liver Disease and Its Risk Factors in Children and Young Adults with Type 1 Diabetes Mellitus.
    Sae-Wong J; Chaopathomkul B; Phewplung T; Chaijitraruch N; Sahakitrungruang T
    J Pediatr; 2021 Mar; 230():32-37.e1. PubMed ID: 33250172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-alcoholic fatty liver disease and complications in type 1 and type 2 diabetes: A Mendelian randomization study.
    Liu N; Wang G; Liu C; Liu J; Huang S; Zhou Y; Xiao E
    Diabetes Obes Metab; 2023 Feb; 25(2):365-376. PubMed ID: 36181433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
    Cuthbertson DJ; Koskinen J; Brown E; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
    Ann Med; 2021 Dec; 53(1):1256-1264. PubMed ID: 34309471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low prevalence of non-alcoholic fatty liver disease in patients with type 1 diabetes is associated with decreased subclinical cardiovascular disease.
    Serra-Planas E; Aguilera E; Castro L; Rodríguez R; Salinas I; Lucas A; Joaquín C; Puig R; Mauricio D; Puig-Domingo M
    J Diabetes; 2017 Dec; 9(12):1065-1072. PubMed ID: 28220621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
    Chakrabarty M; Jha AN; Sharma DJ
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
    Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
    Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: a population-based study.
    Julián MT; Pera G; Soldevila B; Caballería L; Julve J; Puig-Jové C; Morillas R; Torán P; Expósito C; Puig-Domingo M; Castelblanco E; Franch-Nadal J; Cusi K; Mauricio D; Alonso N
    Eur J Endocrinol; 2021 Apr; 184(4):587-596. PubMed ID: 33606661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.